COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,883 Articles (22,568 medRxiv, 8,315 bioRxiv)

Most recent first Previous |  Page 1470: Articles 14691-14700  | Next

T-cell and antibody immunity after COVID-19 mRNA vaccines in healthy and immunocompromised subjects-An exploratory study.
Sindhi, R., Ashokkumar, C., Spishock, B., Saunders, M., Mabasa, A., Sethi, P., Reddy, A., Nibhanupudy, B.
10.1101/2021.05.21.21257442 — Posted: 2021-05-23
Measurement of multiple SARS-CoV-2 antibody titer after vaccination represents individual vaccine response and contributes to individually appropriate vaccination schedules
Ota, K., Yanagihara, K., Murakami, S., Mukae, H., Kohno, S.
10.1101/2021.05.21.21257575 — Posted: 2021-05-23
Clinical, immunological and genomic characterization of asymptomatic and symptomatic cases with SARS-CoV-2 infection, India
Chatterjee, S., Datey, A., Sengupta, S., Ghosh, A., Jha, A., Walia, S., Singh, S., Suranjika, S., Bhattacharya, G., Laha, E., Keshry, S. S., Ray, A., Pani, S. S., Suryawanshi, A., Dash, R., Senapati, S., Beuria, T. K., Syed, G. H., Prasad, P., Raghav, S., Devadas, S., Swain, R., Chattopadhyay, S., Parida, A.
10.1101/2021.05.21.21257211 — Posted: 2021-05-23
Identification and trajectory of growth of concerning SARS-CoV-2 variants in Houston, Texas, January through April 2021 based on 11,568 genome sequences
Olsen, R. J., Christensen, P., Long, S. W., Subedi, S., Hodjat, P., Olson, R., Nguyen, M., Davis, J., Yerramilli, P., Ojeda-Saavedra, M., Pruitt, L., Reppond, K., Shyer, M., Cambric, J., Gadd, R., Finkelstein, I., Gollihar, J., Musser, J.
10.1101/2021.05.20.21257552 — Posted: 2021-05-23
Persistent clotting protein pathology in Long COVID/ Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin
Pretorius, E., Vlok, M., Venter, C., Bezuidenhout, J. A., laubscher, G. J., Steenkamp, J., Kell, D. B.
10.1101/2021.05.21.21257578 — Posted: 2021-05-23
Towards Internationally standardised humoral Immune Correlates of Protection from SARS CoV 2 infection and COVID-19 disease
Castillo-Olivares, J., Wells, D., Ferrari, M., Chan, A., Smith, P., Nadesalingam, A., Paloniemi, M., Carnell, G., Ohlendorf, L., Cantoni, D., Mayora-Neto, M., Palmer, P., Tonks, P., Temperton, N., Neckermann, P., Peterhoff, D., Wagner, R. J., Doffinger, R., Kempster, S., Otter, A., Semper, A., Brooks, T., Page, M., Albecka, A., Briggs, J., James, L., Schwabble, W., Baxendale, D. H., Heeney, J.
10.1101/2021.05.21.21257572 — Posted: 2021-05-23
Heterologous vaccination strategy for containing COVID-19 pandemic
Lin, A., Liu, J., Ma, X., Zhao, F., Yu, B., He, J., Shen, M., Huang, L., Tang, H., Jiang, E., Wang, Y., Cui, P., Zhang, Y., Yao, W., Zhang, A., Wang, Y., Li, Y., Huang, W., Li, Q., Liu, Z., Li, H.
10.1101/2021.05.17.21257134 — Posted: 2021-05-23
A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program
Verma, A., Tsao, N. L., Thomann, L. O., Ho, Y.-L., Carr, R., Crawford, D. C., Efird, J. T., Genovese, G., Hung, A., Ivey, K. L., Iyengar, S. K., Levin, M. G., Luoh, S.-W., Lynch, J., Natarajan, P., Pyarajan, S., Bick, A., Costa, L., Genovese, G., Hauger, R., Madduri, R., Pathak, G. A., Polimanti, R., Voight, B. F., Vujkovic, M., Zekavat, M., Zhao, H., Ritchie, M., Chang, K.-M., Cho, K., Casas, J. P., Tsao, P. S., Gaziano, J. M., O?Donnell, C., Damrauer, S. M., Liao, K. P.
10.1101/2021.05.18.21257396 — Posted: 2021-05-23
Predictors of SARS CoV-2 Infection Among Healthcare Workers: The Impact of Community-Hospital Gradient
Pinarlik, F., Akbulut, Z., Kapmaz, M., Tekin, S., Ergonul, O.
10.1101/2021.05.20.21257518 — Posted: 2021-05-23
DEFINE: A Phase IIa Randomised Controlled Trial to Evaluate Repurposed Treatments for COVID-19
Gaughan, E., Quinn, T. M., Bruce, A., Antonelli, J., Young, V., Mair, J., Akram, A., Hirani, N., Koch, O., Mackintosh, C., Norrie, J., Dear, J. W., Dhaliwal, K.
10.1101/2021.05.20.21257513 — Posted: 2021-05-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).